Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation
about
Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions.Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity.Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repairThe small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis.Involvement of protein kinase C-beta and ceramide in tumor necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells.CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene.PARP-1 inhibits glycolysis in ischemic kidneys.Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans.Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment.
P2860
Q35220416-2EA9F448-7E97-4997-90CB-9531DD17D872Q36367784-489930C7-7763-49D9-A1C3-E46242CB739DQ36380672-F6FE3303-7075-4585-A428-7B1C9F2AB965Q36431155-A38F0B96-98ED-4449-929E-81E06113EA4AQ37410764-38B2BF96-9B0D-4243-B4E8-DD6FE8885039Q38522653-B5F18198-D9B4-4C89-AB4C-058103C40E4EQ39446494-D2942292-B044-4391-AFF1-D7B693007879Q40937114-4E8774B8-94B3-481B-9ED7-4070CEA7B71AQ40953967-E02EA6AC-1219-4A99-9383-FA03272735FBQ42145671-022AED97-096D-44B6-9DEE-32DA468CC7C6Q42155614-1DC90907-BD7F-4B87-82A4-B68CCEA84BFFQ43210220-A465A202-683E-4F35-9FAF-FF86522A3E8CQ46231615-7E551EFA-B7E9-4814-A1DF-5E04A44C4D91Q53694785-0AAB648D-5160-421C-B8A6-5C504A171694
P2860
Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Biochemical pathways of apopto ...... protease and DNA fragmentation
@ast
Biochemical pathways of apopto ...... protease and DNA fragmentation
@en
type
label
Biochemical pathways of apopto ...... protease and DNA fragmentation
@ast
Biochemical pathways of apopto ...... protease and DNA fragmentation
@en
prefLabel
Biochemical pathways of apopto ...... protease and DNA fragmentation
@ast
Biochemical pathways of apopto ...... protease and DNA fragmentation
@en
P2093
P2860
P356
P1476
Biochemical pathways of apopto ...... protease and DNA fragmentation
@en
P2093
P2860
P304
P356
10.1084/JEM.183.2.463
P407
P577
1996-02-01T00:00:00Z